IP Library › Granted Patent US 9,517,251
Granted Patent B2
US 9,517,251 · App. 14/219,541 · Granted Dec 13, 2016

Methods for generating cardiomyocytes

Inventors: Deepak Srivastava (San Francisco, CA); Masaki Ieda (Tokyo, JP)
Assignee: The J. David Gladstone Institutes
A61K38/02A61K35/34A61K38/1709C12N5/0657C12N15/85C12N2501/60C12N2506/1307C12N2510/00C12N2740/13043
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,517,251
App. No.
14/219,541
Granted
Dec 13, 2016
Kind
B2
Abstract

The present disclosure provides method of generating cardiomyocytes from post-natal fibroblasts. The present disclosure further provides cells and compositions for use in generating cardiomyocytes.

Claims (10)

1. An in vivo method of generating an induced cardiomyocyte, the method consisting of:

genetically modifying a rodent post-natal fibroblast with one or more nucleic acids encoding only three reprogramming factor polypeptides, wherein the three reprogramming factor polypeptides consist of Gata4, Mef2c, and Tbx5, and wherein said genetic modification results in direct reprogramming of the rodent post-natal fibroblast into a cardiomyocyte, thereby generating an induced cardiomyocyte.

2. The method of claim 1 , wherein said one or more nucleic acids is a recombinant vector.

3. The method of claim 1 , wherein said one or more nucleic acids are operably linked to a transcription regulatory element.

4. The method of claim 3 , wherein the transcription regulatory element is a constitutive promoter functional in the post-natal fibroblast.

5. An in vivo method of generating an induced cardiomyocyte, the method consisting of:

genetically modifying a rodent post-natal fibroblast with one or more nucleic acids encoding only three reprogramming factor polypeptides, wherein the three reprogramming factor polypeptides consist of Gata4, Mef2c, and Tbx5, and wherein said genetic modification results in direct reprogramming of the rodent post-natal fibroblast into a cardiomyocyte, thereby generating an induced cardiomyocyte; and

isolating the induced cardiomyocyte.

6. The method of claim 1 , wherein the three reprogramming factor polypeptides are encoded by a single nucleic acid.

7. The method of claim 5 , wherein the three reprogramming factor polypeptides are encoded by a single nucleic acid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2014
From: SRIVASTAVA, DEEPAK; IEDA, MASAKI
To: THE J. DAVID GLADSTONE INSTITUTES
Reel/Frame 033103/0449 →
Continuity (4)
Division 13642391
Provisional Application 61364295 · Jul 14, 2010
Provisional Application 61328988 · Apr 28, 2010
Related Publication 20140235526A1 · Aug 21, 2014